Ocular Hypertension (Glaucoma, Suspect) Summary

Networked: 1905 relevant articles (185 outcomes, 396 trials/studies) for this Disease

Key Drugs and Agents for Ocular Hypertension

1. Timolol (Blocadren) : 70 outcomes 111 studies in 371 results : FDA 56 Generic
   
2. latanoprost (Xalatan) : 43 outcomes 92 studies in 273 results : FDA 3
   
3. bimatoprost (Lumigan) : 26 outcomes 35 studies in 115 results : FDA 3
   
4. travoprost (Travatan) : 26 outcomes 33 studies in 112 results : FDA 2
   
5. brimonidine (Alphagan) : 24 outcomes 40 studies in 106 results : FDA 12 Generic
   
6. dorzolamide (Trusopt) : 24 outcomes 39 studies in 103 results : FDA 15 Generic
   
7. brinzolamide (Azopt) : 18 outcomes 30 studies in 57 results : FDA 1
   
8. Levobunolol (AKBeta) : 9 outcomes 5 studies in 31 results : FDA 10 Generic
   
9. hydroxide ion : 8 outcomes 24 studies in 135 results : IBA
   
10. Betaxolol (Kerlon) : 6 outcomes 8 studies in 23 results : FDA 11 Generic
    

Diseases Related to Ocular Hypertension

1. Open-Angle Glaucoma (Glaucoma, Open Angle)
2. Glaucoma
3. Low Tension Glaucoma
4. Cataract (Cataracts)
5. Hyperemia

Key Therapies for Ocular Hypertension

1. Trabeculectomy (Trabeculoplasty) : 13 outcomes 8 studies in 54 results
   
2. Lasers (Laser) : 12 outcomes 27 studies in 157 results
   
3. Injections : 2 outcomes 1 study in 16 results
   
4. Phacoemulsification : 2 outcomes in 27 results
   
5. Intraocular Lenses (Intraocular Lens) : 2 outcomes in 9 results